Getting your Trinity Audio player ready...
Abbott Laboratories achieved record sales and earnings for the fourth quarter and all of 1993.
Profits in the quarter rose 12.1 percent, mainly on strong sales of Abbott’s drugs and nutritional products, to $391.3 million, or 48 cents a share, from $349 million, or 42 cents a share, a year earlier. Sales rose 6.3 percent, to $2.23 billion from $2.1 billion.
Sales of pharmaceutical and nutritional products jumped 10.7 percent from a year earlier.
For the full year, North Chicago-based Abbott’s profits were up 12.9 percent, to $1.4 billion, or $1.69 a share, from $1.2 billion, or $1.47 a share, in 1992. Sales climbed 7.1 percent, to $8.4 billion from $7.9 billion.
